Prescription drug · ANDA
Eltrombopag NDC 70771-1925
Eltrombopag olamine 12.5 mg/1 · Tablet · Oral · Zydus Lifesciences Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70771-1925-3 | 7077119250370771192503 | 30 TABLET in 1 BOTTLE (70771-1925-3)Marketed from Jan 14, 2026 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Eltrombopag
- Generic name (nonproprietary)
- eltrombopag
- Active ingredients
- Eltrombopag olamine — 12.5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Zydus Lifesciences LimitedNDC labeler code 70771
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 216281
- Marketing start
- Listing expires
- Other FDA classes
- Breast Cancer Resistance Protein Inhibitors (Mechanism)Increased Megakaryocyte Maturation (Physiologic effect)Increased Platelet Production (Physiologic effect)Organic Anion Transporting Polypeptide 1B1 Inhibitors (Mechanism)Thrombopoietin Receptor Agonists (Mechanism)UGT1A1 Inhibitors (Mechanism)UGT1A3 Inhibitors (Mechanism)UGT1A4 Inhibitors (Mechanism)UGT1A6 Inhibitors (Mechanism)UGT1A9 Inhibitors (Mechanism)UGT2B15 Inhibitors (Mechanism)UGT2B7 Inhibitors (Mechanism)
- Identifiers
- Product ID 70771-1925_5273da92-fa13-4b26-b32f-63955b1983c3SPL ID 5273da92-fa13-4b26-b32f-63955b1983c3SPL set ID ae9a7725-64f8-406d-88e7-e6e01136deaeRxCUI 825421, 825427, 884617, 1245001UNII 4U07F515LG
- Pharmacologic class
- Thrombopoietin Receptor Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470771192503followed by a unit qualifier and the quantityPackage 70771-1925-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
About NDC 70771-1925
- What is NDC 70771-1925?
- 70771-1925 is the product NDC for Eltrombopag, Eltrombopag olamine 12.5 mg/1 tablet, listed with the FDA by Zydus Lifesciences Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Eltrombopag.
- What is the active ingredient?
- Eltrombopag olamine.
- Who is the labeler?
- Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Eltrombopag?
- 37 other product NDCs are listed under this name. See all Eltrombopag NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Eltrombopag products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Eltrombopag | Eltrombopag olamine 50 mg/1 | Tablet, Film coatedOral | Teva Pharmaceuticals, Inc. | 0480-2600 | 00480-2600-56 |
| Eltrombopag | Eltrombopag olamine 12.5 mg/1 | Tablet, Film coatedOral | Teva Pharmaceuticals, Inc. | 0480-4015 | 00480-4015-56 |
| Eltrombopag | Eltrombopag olamine 75 mg/1 | Tablet, Film coatedOral | Teva Pharmaceuticals, Inc. | 0480-4031 | 00480-4031-56 |
| Eltrombopag | Eltrombopag olamine 25 mg/1 | Tablet, Film coatedOral | Teva Pharmaceuticals, Inc. | 0480-4210 | 00480-4210-56 |
| Eltrombopag | Eltrombopag olamine 12.5 mg/1 | Tablet, Film coatedOral | Biocon Pharma Inc. | 70377-183 | 70377-0183-11 |
| Eltrombopageltrombopag olamine | Eltrombopag olamine 25 mg/1 | Tablet, Film coatedOral | Biocon Pharma Inc. | 70377-184 | 70377-0184-1170377-0184-12 |
| Eltrombopageltrombopag olamine | Eltrombopag olamine 50 mg/1 | Tablet, Film coatedOral | Biocon Pharma Inc. | 70377-185 | 70377-0185-1170377-0185-1270377-0185-13 |
| Eltrombopageltrombopag olamine | Eltrombopag olamine 75 mg/1 | Tablet, Film coatedOral | Biocon Pharma Inc. | 70377-186 | 70377-0186-1170377-0186-12 |
| Eltrombopageltrombopag olamine | Eltrombopag olamine 12.5 mg/1 | TabletOral | Hikma Pharmaceuticals USA Inc. | 0054-0962 | 00054-0962-13 |
| Eltrombopageltrombopag olamine | Eltrombopag olamine 25 mg/1 | TabletOral | Hikma Pharmaceuticals USA Inc. | 0054-0963 | 00054-0963-13 |
Other NDCs under ANDA 216281
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Eltrombopag | Eltrombopag olamine 12.5 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 70710-1395 |
| Eltrombopag | Eltrombopag olamine 25 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 70710-1396 |
| Eltrombopag | Eltrombopag olamine 50 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 70710-1397 |
| Eltrombopag | Eltrombopag olamine 75 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 70710-1398 |
| Eltrombopag | Eltrombopag olamine 25 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1926 |
| Eltrombopag | Eltrombopag olamine 50 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1927 |
| Eltrombopag | Eltrombopag olamine 75 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1928 |